22NW Fund, LP's Form 4 filing
Lifecore Biomedical, Inc. DE (LFCR) · filed May 12, 2025
- Accession no.
- 0000950170-25-069576
- Filed
- May 12, 2025, 6:58 PM ET
- Trade date
- May 8-12, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $362.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| 22NW Fund, LPCIK 0001640809 | 10% Owner |
| 22NW, LPCIK 0001694297 | 10% Owner |
| English Aron R.CIK 0001770436 | 10% Owner |
| 22NW Fund GP, LLCCIK 0001770575 | 10% Owner |
| 22NW GP, Inc.CIK 0001783663 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | Common Stock | SSaleDisposed | −5,098 | $7.00 | −$35,693.14 | 1,708,972 | Indirect | |
| May 9, 2025 | Common Stock | SSaleDisposed | −700 | $7.00 | −$4,900 | 1,708,272 | Indirect | |
| May 12, 2025 | Common Stock | SSaleDisposed | −45,698 | $7.03 | −$321,426.02 | 1,662,574 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.